Arkolith/Insider Trading/ALMR/Form 4

Chen Shiping

Chief Operating Officer, DirectorAlamar Biosciences, Inc. (ALMR) · full profile →Form 4 · filed Apr 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
13
5 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 20, 2026Other(J)723K——0
Apr 20, 2026Other(J)723K—$0723K
Apr 20, 2026Grant(A)37K—$0760K
Apr 20, 2026Conversion(C)321K——650K
Apr 20, 2026Conversion(C)73K——723K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Other(J)301K—$0301K
Apr 20, 2026Other(J)12K—$00
Apr 20, 2026Other(J)12K—$012K
Apr 20, 2026Conversion(C)247K—$00
Apr 20, 2026Conversion(C)73K—$00
Apr 20, 2026Conversion(C)176K—$00
Apr 20, 2026Other(J)301K—$00
Apr 16, 2026Grant(A)163K—$0163K

Transaction Codes

J
Other acquisition / disposition
A
Grant / award
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002126944-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML